Showing results (821-830 of 2,106) with videos related to
Sort By:
Pageof 211
CNS Drugs|May 2, 2025
Relationship between Tranexamic Acid Use and Safety in Patients with Acute Brain Injury: A Systematic Review and Meta-analysis of Mortality and Thromboembolic EventsSeungjoo Lee, Moinay Kim, Sae Min Kwon, et al.CNS Drugs|November 7, 2025
New and Emerging Therapies for Patients with Low-Grade GliomaKatherine B PetersCNS Drugs|November 10, 2025
Cerebral Aspergillosis: Diagnostic Challenges, Therapeutic Strategies, and Future ResearchLouise Chantelot, Emilie Sitterlé, Sylvain Poirée, et al.CNS Drugs|September 23, 2025
Prioritizing Antihypertensive Agents in Secondary Prevention of Ischemic Stroke: A Retrospective Population-Based StudyHsin-Yu Chen, Wei-Kai Lee, Yao-Min Hung, et al.CNS Drugs|August 7, 2025
Clinically Meaningful Reduction in Drop Seizures in Patients with Lennox-Gastaut Syndrome Treated with Cannabidiol: Post Hoc Analysis of Phase 3 Clinical TrialsNicola Specchio, Stéphane Auvin, Teresa Greco, et al.CNS Drugs|September 11, 2025
Impact of Long-Acting Injectable Versus Oral Antipsychotic Treatment on All-Cause Discontinuation Risk in People with Early Phase Schizophrenia and Comorbid Substance Use Disorder: A Secondary Analysis of the EULAST Randomized TrialMatin Mortazavi, Zahra Aminifarsani, Inge Winter-van Rossum, et al.CNS Drugs|September 9, 2025
Statins in Acute Ischemic Stroke: Mechanisms, Resistance, and Precision Strategies for Neurovascular and Cognitive ProtectionMuskaan Gupta, Ivica Smokovski, Dimitrios G Chatzis, et al.CNS Drugs|September 18, 2025
Sigma-1 Receptor Ligands for CNS Cancer TreatmentAnchalee Prasansuklab, Stephen T Safrany, Sirikalaya Brimson, et al.CNS Drugs|October 16, 2025
Managing Chronic Pain: The Ketamine OptionGisèle Pickering, Véronique Morel, Marion VouteCNS Drugs|October 17, 2025
The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI CohortPatrick Silva, Marina A Costa, Laetitia Gaspar, et al.Pageof 211